CRO/Sponsor Articles

Jul 08, 2015
Applied Clinical Trials
Proposed partnership model explores the value of establishing alliances between CROs and networks of small and emerging biopharma companies.
Feb 19, 2015
Applied Clinical Trials
Recent advances in proteomics, genomics and metabolomics have enabled us to understand the molecular basis of disease at both the diagnostic and treatment levels.
Jan 22, 2015
Applied Clinical Trials
Over recent years global drug companies large or small have recognized that one root cause of the high failure rate in their clinical development lies in the selection of right therapeutic targets.
Sep 30, 2014
Applied Clinical Trials
Exploring sourcing model options for appropriate incorporation of DMCs into a clinical program.
Sep 10, 2014
Applied Clinical Trials
Why do we audit our suppliers and what do we hope to achieve when we do?
Aug 19, 2014
Applied Clinical Trials
Implementing a "just-in-time" site activation process effectively can significantly speed trial startup.
Jul 06, 2014
Applied Clinical Trials
The costs of drug development are increasing, driven in large part by increasing failure rates in all phases of clinical development.
Jun 25, 2014
Applied Clinical Trials
PCORI underscored existing trends toward increasingly individualized and personalized medical care...
Jun 23, 2014
Applied Clinical Trials
Pharmacovigilance is the next frontier for outsourcing in the pharmaceutical and biologics industry.
May 31, 2014
Applied Clinical Trials
A two-phase statistical analysis identifies the key performance drivers in clinical trial startup.

CRO/Sponsor News

Covance Co-Locates Facility for Increased Patient Exposure

LabCorp® announced that Covance Drug Development has relocated its clinical research unit in Dallas, TX, to a new, fit-for-purpose clinical research facility.

OmniComm Systems® Forms Reseller Agreement with Tri-I Biotech Shanghai

OmniComm Systems, a global provider of clinical data management technology and services, announced that it has signed a reselling partnership agreement with Tri-I Biotech Shanghai Inc.

Almac Group Expands Asia Pacific Presence

Almac Group announced the successful completion of the Health Sciences Authority (HSA) inspection of its new Asia Pacific headquarters in Singapore.

Parexel Expands Model-Based Drug Development Offering

Parexel announced expanded services and capabilities in model-based drug development (MBDD) through its Quantitative Clinical Development (QCD) group.

Certara Creates Global Strategic Modeling and Simulation Consultancy

Certara®, a global biosimulation technology-enabled drug development company, announced the merger of its consulting group, Pharsight Consulting Services.